H.R. 4395 · 108th Congress
Ephedrine Alkaloids Regulation Act of 2004
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 108th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
CarsonSponsor5 cosponsors · 4 D, 1 R
1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Ephedrine Alkaloids Regulation Act of 2004 - Requires ephedrine alkaloids, including ephedrine and pseudoephedrine, to be listed in schedule V (drugs or other substances having a low potential for abuse, that have a currently accepted medical use in treatment in the United States, abuse of which may lead to limited physical or psychological dependence) of…
What it does: CRS summary · Introduced in House · May 19, 2004
Ephedrine Alkaloids Regulation Act of 2004 - Requires ephedrine alkaloids, including ephedrine and pseudoephedrine, to be listed in schedule V (drugs or other substances having a low potential for abuse, that have a currently accepted medical use in treatment in the United States, abuse of which may lead to limited physical or psychological dependence) of the Controlled Substances Act (CSA). Excepts pseudoephedrine when contained in a drug that is in liquid or gel form marketed or distributed lawfully in the United States under the Federal Food, Drug, and Cosmetic Act (which shall be considered a listed chemical).
Amends CSA to revise the definition of: (1) "regulated transaction" to provide that the threshold for any distributor sale of products containing pseudoephedrine products in liquid or gel form, or containing phenylpropanolamine products, shall be nine grams of pseudoephedrine or phenylpropanolamine in a single transaction and sold in package sizes of not more than three grams of pseudoephedrine or phenylpropanolamine base; and (2) "ordinary over-the-counter pseudoephedrine or phenylpropanolamine product" to mean certain products containing pseudoephedrine in liquid or gel form (currently, products containing pseudoephedrine) that meet specified requirements.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Ephedrine Alkaloids Regulation Act of 2004
Latest action (Jun 28, 2004): Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Policy area: Crime and Law Enforcement · Origin: House · Introduced: May 19, 2004
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.